Shilpa Medicare informs about disclosure

27 Jan 2024 Evaluate
Shilpa Medicare has informed that the company, Unit 4, Jadcherla, Telangana, India had Europe GMP inspection by AGES, Austria from 22 January, 2024 until 26 January, 2024. This inspection has concluded with two minor observations. The previous EU – GMP inspection for this facility was in January 2020. This Unit of Shilpa Medicare is engaged in the manufacture, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in the US, Europe and rest of the world markets. The Company intends to respond to the two minor observations within the stipulated time and is committed for the satisfactory resolution of the inspectional observations and sustained cGMP compliance.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

331.30 -2.65 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×